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A total of 360 weanling barrows (Line 200 × 400, DNA Genetics; initial BW 12.4 ± 0.05 lb) were used in a 
42-d study to evaluate yeast-based pre- and probiotics (Phileo by Lesaffre, Milwaukee, WI) in diets with or 
without pharmacological levels of Zn on growth performance and fecal dry matter (DM). Pens were 
assigned to 1 of 4 dietary treatments with 5 pigs per pen and 18 pens per treatment. Dietary treatments 
were arranged in a 2 × 2 factorial with main effects of live yeast-based pre- and probiotics (none vs. 0.10% 
ActiSaf Sc 47 HR+, 0.05% SafMannan, and 0.05% NucleoSaf from d 0 to 7, then concentrations were 
lowered by 50% from day 7 to 21) and pharmacological levels of Zn (110 vs. 3,000 ppm from d 0 to 7, and 
2,000 ppm from d 7 to 21 provided by ZnO). All pigs were fed a common diet from d 21 to 42 post-
weaning. There were no yeast × Zn interactions or effects due to yeast additives observed on any 
response criteria. From d 0 to 21 and d 0 to 42, pigs fed pharmacological levels of Zn had increased (P < 
0.001) ADG and ADFI. Fecal samples were collected on d 4, 21, and 42 from the same three pigs per pen 
for DM analysis. On d 4, pigs fed pharmacological levels of Zn had greater fecal DM (P = 0.043); however, 
no differences were observed on d 21 or 42. In conclusion, pharmacological levels of Zn increased ADG, 
ADFI, and d 4 post-weaning fecal DM. There was no response observed from live yeast and yeast extracts 
for any growth or fecal DM criteria. 
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Summary
A total of 360 weanling barrows (Line 200 × 400, DNA Genetics; initial BW 12.4 ± 
0.05 lb) were used in a 42-d study to evaluate yeast-based pre- and probiotics (Phileo 
by Lesaffre, Milwaukee, WI) in diets with or without pharmacological levels of Zn on 
growth performance and fecal dry matter (DM). Pens were assigned to 1 of 4 dietary 
treatments with 5 pigs per pen and 18 pens per treatment. Dietary treatments were 
arranged in a 2 × 2 factorial with main effects of live yeast-based pre- and probiotics 
(none vs. 0.10% ActiSaf Sc 47 HR+, 0.05% SafMannan, and 0.05% NucleoSaf from 
d 0 to 7, then concentrations were lowered by 50% from day 7 to 21) and pharmaco-
logical levels of Zn (110 vs. 3,000 ppm from d 0 to 7, and 2,000 ppm from d 7 to 21 
provided by ZnO). All pigs were fed a common diet from d 21 to 42 post-weaning. 
There were no yeast × Zn interactions or effects due to yeast additives observed on any 
response criteria. From d 0 to 21 and d 0 to 42, pigs fed pharmacological levels of Zn 
had increased (P < 0.001) ADG and ADFI. Fecal samples were collected on d 4, 21, and 
42 from the same three pigs per pen for DM analysis. On d 4, pigs fed pharmacological 
levels of Zn had greater fecal DM (P = 0.043); however, no differences were observed 
on d 21 or 42. In conclusion, pharmacological levels of Zn increased ADG, ADFI, and 
d 4 post-weaning fecal DM. There was no response observed from live yeast and yeast 
extracts for any growth or fecal DM criteria. 
Introduction
Feeding pharmacological levels of Zn (2,000 to 3,000 ppm) in the early nursery has 
been an industry-wide practice used to improve growth performance and control 
instances of post-weaning diarrhea. However, feeding pharmacological levels of Zn has 
become an environmental concern and a concern for antimicrobial resistance (AMR) 
to antibiotics of importance to human and animal medicine.
1 Department of Diagnostic Medicine/Pathology, College of Veterinary Medicine, Kansas State Univer-
sity.
2 Department of Statistics, College of Arts and Sciences, Kansas State University.
3 Phileo by Lesaffre, Milwaukee, WI.
2
Swine Day 2021
Kansas State University Agricultural Experiment Station and Cooperative Extension Service
One potential replacement strategy for pharmacological levels of added Zn in the early 
nursery is the use of pre- and probiotics. Feeding probiotics can alter the gut’s micro-
flora by introducing live cultures of beneficial microorganisms into the digestive tract 
and can aid in suppressing their pathogenic counterparts. The improved microbial 
profile in the gut may allow the pig to have more protection against enteric diseases 
while subsequently improving growth performance.4 Our hypothesis was that the 
additions of a live yeast (probiotic) and yeast extracts (prebiotics) would provide equal, 
if not additive growth responses to added Zn. Thus, the objective of this study was to 
determine the effects of pharmacological levels of Zn with or without the addition of 
the live yeast Saccharomyces cerevisiae strain NCYC Sc 47 and yeast-based prebiotics 
derived from Saccharomyces cerevisiae on nursery pig growth performance and fecal dry 
matter. 
Materials and Methods 
General
The Kansas State University Institutional Animal Care and Use Committee approved 
the protocol used in this experiment. The study was conducted at the Kansas State 
University Segregated Early Weaning Facility in Manhattan, KS. The facility has two 
identical barns that are completely enclosed, environmentally controlled, and mechani-
cally ventilated. Treatments were equally represented in each barn. Each pen contained 
a 4-hole, dry self-feeder and a cup waterer to provide ad libitum access to feed and 
water. Pens (4 × 4 ft) had metal tri-bar floors and allowed approximately 2.7 ft2/pig. 
Animals and treatment structure
A total of 360 barrows (Line 200 × 400, DNA; initial BW 12.4 ± 0.05 lb) were used 
in a 42-d study with 5 pigs per pen and 18 pens per treatment (9 pens per barn). Upon 
arrival to the research site, pigs were randomly assigned to pens. Pens were then assigned 
to 1 of 4 dietary treatments in a randomized complete block design with pens blocked 
by BW. Pigs were healthy from placement throughout the trial with only three pigs 
being removed from the study. 
Dietary treatments were arranged in a 2 × 2 factorial with main effects of yeast-based 
pre- and probiotics (none vs. 0.10% ActiSaf Sc 47 HR+, 0.05% SafMannan, and 0.05% 
NucleoSaf from d 0 to 7, then concentrations were lowered by 50% from day 7 to 21; 
Table 1) and pharmacological levels of Zn (110 vs. 3,000 ppm from d 0 to 7, and 
2,000 ppm from d 7 to 21 provided by ZnO). All pigs were fed a common diet from 
d 21 to 42 post-weaning without added yeast products or pharmacological levels of Zn. 
The live yeast Saccharomyces cerevisiae strain NCYC Sc 47 (ActiSaf Sc 47 HR+; Phileo 
by Lesaffre, Milwaukee, WI) served as the yeast-based probiotic. The yeast-based prebi-
otics included a yeast cell wall fraction with concentrated mannan-oligosaccharides and 
β-glucans from Saccharomyces cerevisiae (SafMannan; Phileo by Lesaffre, Milwaukee, 
WI) and a yeast extract containing ≥6% unbound nucleotides from Saccharomyces cere-
visiae (NucleoSaf; Phileo by Lesaffre, Milwaukee, WI). 
4 Liao, S. F., and M. Nyachoti. 2017. Using probiotics to improve swine gut health and nutrient utiliza-
tion. Animal Nutrition. 3:331-343. doi:10.1016/j.aninu.2017.06.007.
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Diet preparation
Phase 1 diets were formulated to a 1.40% standardized ileal digestible (SID) Lys, and 
phase 2 and 3 diets were formulated to 1.35 % SID Lys (Table 1). All other nutrients 
were formulated to meet or exceed NRC (2012)5 requirement estimates. Phase 1 and 2 
diets were manufactured at the Kansas State University Poultry Unit (Manhattan, KS), 
and the common phase 3 diet was manufactured at a commercial feed mill (Hubbard 
Feeds; Beloit, KS). All three phases were fed in meal form. Pens of pigs were weighed 
and feed disappearance recorded weekly during the course of this study to determine 
ADG, ADFI, and F/G. 
Chemical analysis
Phase 1 and 2 diet samples were collected at manufacturing and phase 3 diets were 
collected from multiple 50-lb bags using a feed probe to collect a representative sample 
for each respective diet and phase. Complete diet samples were stored at -4°F until 
they were homogenized, subsampled, and submitted for analysis. Duplicate composite 
samples per dietary treatment were analyzed (Ward Laboratories; Kearney, NE) for dry 
matter, crude protein, and Zn. Separate composite samples per dietary treatment were 
analyzed (Analabs; Fulton, IL) for active live yeast for phases 1 and 2 (Table 2). 
Fecal collection
Fecal samples were collected on d 4, 21, and 42 of the experiment for fecal antimicrobial 
resistance profiles of E. coli and fecal dry matter analysis. Fecal samples were collected 
directly from the rectum of the same three randomly selected pigs from each pen and 
pooled by pen to form one composite sample. Fecal samples were stored at -4°F until 
fecal DM analysis. Fecal samples were pooled by pen, respective of day of collection, and 
dried at 131°F in a forced air oven for 48 h. 
Economics
Total feed cost per pig, cost per lb of gain, revenue, and income over feed cost (IOFC) 
were calculated to evaluate the economics of including yeast additives and ZnO. Feed 
cost per pig placed was determined by multiplying total feed intake by diet cost. Feed 
cost per lb of gain was calculated by dividing the total feed cost per pig by the total 
weight gained. Revenue per pig placed was determined by total gain times the dressing 
percentage (0.75) and then multiplied by $0.70 carcass price in order to convert to a live 
price. Income over feed cost was calculated using revenue per pig placed minus feed cost 
per pig placed. For all economic evaluations, the following ingredients prices were used: 
corn = $7.06/bushel ($252/ton); soybean meal = $367/ton; L-Lys HCl = $0.80/lb; 
DL-methionine = $2.20/lb; MHA =$2.25/lb; L-threonine = $1.01/lb; L-tryptophan 
= $3.99/lb; L-valine = $2.32/lb; ZnO = $1.09/lb; ActiSaf Sc 47 HR+ = $2.80/lb; 
SafMannan = $1.40/lb; and NucleoSaf = $8.20/lb.
Statistical analysis
Growth performance, economics, and fecal dry matter data were analyzed using the 
nlme package of R (Version 4.0.0, R Foundation for Statistical Computing, Vienna, 
Austria) as a randomized complete block design with body weight as the blocking factor 
and pen as the experimental unit. The main effects of yeast-derived probiotics and phar-
5 National Research Council. 2012. Nutrient Requirements of Swine: Eleventh Revised Edition. Wash-
ington, DC: The National Academies Press. https://doi.org/10.17226/13298.
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macological levels of Zn, as well as their interactions, were tested. Differences between 




There were no interactions observed between the dietary addition of pharmacological 
levels of Zn and yeast-based pre- and probiotics (Table 3). Thus, the main effects of 
Zn and yeast additives are reported (Table 4). There was no evidence for difference 
(P > 0.10) when live yeast and yeast extracts were included in the diet for any of the 
response criteria for the entirety of the study. 
In phase 1 (d 0 to 7) and phase 2 (d 7 to 21), pigs fed diets with pharmacological levels 
of Zn had increased (P < 0.05) ADG, ADFI, and d 7 and 21 BW; but there was no 
difference (P > 0.10) in F/G compared to those that were not fed pharmacological 
levels of Zn.  
For the overall experimental period (d 0 to 21), pigs fed pharmacological levels of Zn 
had increased (P < 0.001) ADG and ADFI. However, there was no evidence for differ-
ence (P > 0.10) in F/G between those that were fed diets with or without added Zn or 
yeast additives on any response criteria. During the common period (d 21 to 42), there 
was no evidence for difference (P > 0.10) between any of the previous treatment combi-
nations on growth performance. 
For the overall study (d 0 to 42), pigs fed pharmacological levels of Zn had increased 
(P < 0.05) ADG, ADFI, improved F/G and heavier d 42 BW. There were no differ-
ences observed for pigs fed yeast-based pre- and probiotics.
Fecal dry matter 
There were no interactions observed between the dietary addition of pharmacological 
levels of Zn and yeast-based pre- and probiotics or for the main effect of yeast additives 
for fecal dry matter. On d 4, pigs fed 3,000 ppm of Zn had greater fecal DM (P = 0.039) 
than those without added Zn. However, no differences were observed on d 21 or 42 
between any of the dietary treatments for fecal DM.
Economics
No interactions between the addition of live yeast and pharmacological Zn were 
observed for any economic criteria. There was a tendency (P = 0.062) for increased feed 
cost per pig when yeast additives were included in the diet compared to a diet without 
yeast; however, there was no evidence for difference (P = 0.923) for feed cost per lb of 
gain. While there was no statistical difference (P > 0.10) between diets with or without 
yeast-based pre- and probiotics, pigs fed yeast had a numerical increase in revenue 
(+$0.53) and IOFC (+$0.19). Pigs fed pharmacological levels of Zn, provided by ZnO, 
had a tendency (P = 0.076) for increased feed cost per pig compared to those fed diets 
without added ZnO; yet, pigs fed pharmacological levels of Zn had lower (P = 0.014) 
feed cost per lb of gain. Furthermore, pigs fed added ZnO had increased (P < 0.005) 
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In conclusion, adding pharmacological levels of Zn has proven to be a useful additive 
to stimulate feed intake, increase growth, and improve fecal DM in the early nursery 
period. There was no statistical response observed from the dietary addition of live yeast 
and yeast extracts for any of the growth or fecal DM criteria. 
Brand names appearing in this publication are for product identification purposes only. 
No endorsement is intended, nor is criticism implied of similar products not mentioned. 
Persons using such products assume responsibility for their use in accordance with current 
label directions of the manufacturer.
Table 1. Composition of phase 1 and phase 2 diets (as-fed basis)1
Item Phase 1 Phase 2 Phase 3
Ingredients, %
Corn 43.98 57.10 64.70
Soybean meal (46.5% CP) 18.10 26.35 31.30
Whey powder 25.00 10.00 ---
Fish meal 4.50 --- ---
Enzymatically-treated soybean meal2 3.75 2.00 ---
Soybean oil 1.50 --- ---
Calcium carbonate 0.30 0.90 0.85
Monocalcium P (21% P) 0.48 1.10 1.00
Salt 0.30 0.55 0.60
L-Lys-HCl 0.43 0.51 0.52
DL-Met 0.22 0.22 ---
MHA3 --- --- 0.25
L-Thr 0.18 0.21 0.22
L-Trp 0.07 0.06 0.06
L-Val 0.13 0.14 0.13
Vitamin premix4 0.25 0.25 ---
Vitamin premix with phytase5 --- --- 0.25
Trace mineral premix6 0.15 0.15 0.15
Phytase7 0.08 0.08 ---
Zinc oxide8 ± ± ---
Yeast additives9 ± ± ---
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Table 1. Composition of phase 1 and phase 2 diets (as-fed basis)1
Item Phase 1 Phase 2 Phase 3
Calculated analysis
SID amino acids, %
Lys 1.40 1.35 1.35
Ile:Lys 56 55 55
Leu:Lys 109 111 114
Met:Lys 38 36 36
Met and Cys:Lys 57 57 57
Thr:Lys 63 63 63
Trp:Lys 20.6 20.2 20.3
Val:Lys 69 69 69
His:Lys 32 34 36
Total Lys, % 1.53 1.48 1.49
ME, kcal/lb 1,548 1,485 1,487
NE, kcal/lb 1,166 1,104 1,098
SID Lys:NE, g/Mcal 5.44 5.54 5.57
CP, % 20.9 20.5 21.2
Ca, % 0.69 0.77 0.72
P, % 0.68 0.66 0.61
STTD P, % 0.63 0.58 0.50
Zn, ppm 110 vs 3,000 110 vs 2,000 110
1Phase 1 diets were fed from d 0 to 7 (approximately 12.4 to 13.4 lb BW), and phase 2 diets were fed from d 7 to 21 
(approximately 13.4 to 25.5 lb BW). A common diet, without ZnO or yeast probiotics, was fed during phase 3 from 
d 21 to 42 (approximately 25.5 to 53.0 lb BW).
2HP 300, Hamlet Protein, Findlay, OH.
3Methionine hydroxy analogue, Novus International, St. Charles, MO.
4Provided per lb of premix: 750,000 IU vitamin A; 300,000 IU vitamin D; 8,000 IU vitamin E; 600 mg vitamin K; 6 
mg vitamin B12; 9,000 mg niacin; 5,000 mg pantothenic acid; 1,500 mg riboflavin.
5Ronozyme HiPhos GT 2700 (DSM Nutritional Products, Parsippany, NJ) provided 566 FTU/lb and an estimated 
release of 0.12% STTD P. Provided per lb of premix: 750,000 IU vitamin A; 300,000 IU vitamin D; 8,000 IU 
vitamin E; 600 mg vitamin K; 6 mg vitamin B12; 9,000 mg niacin; 5,000 mg pantothenic acid; 1,500 mg riboflavin.
6Provided per lb of premix: 73 g Zn from zinc sulfate; 73 g Fe from iron sulfate; 22 g Mn from manganese oxide; 11 g 
Cu from copper sulfate; 0.2 g I from calcium iodate; 0.2 g Se from sodium selenite.
7Ronozyme HiPhos 2700 (DSM Nutritional Products, Parsippany, NJ) provided 918 FTU/lb and an estimated 
release of 0.12% STTD P in phases 1 and 2. 
8ZnO was fed to supply 3,000 ppm of Zn for the duration of phase 1 and 2,000 ppm of Zn for the duration of phase 
2.
9Yeast pre- and probiotics included 0.10% ActiSaf Sc 47 HR+, 0.05% SafMannan, and 0.05% NucleoSaf in phase 1 
diets, and then concentrations were lowered by 50% in phase 2 diets (Phileo by Lesaffre, Milwaukee, WI).
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Table 2. Diet analysis (as-fed basis), %1
No yeast probiotics Yeast probiotics2 
Low Zn High Zn Low Zn High Zn
Phase 1 diets
DM, % 91.8 91.9 91.9 91.9
CP, % 20.5 19.9 20.2 20.1
Ca, % 1.23 1.23 1.20 1.20
P, % 0.77 0.75 0.77 0.76
Zn, ppm 263 3,230 245 3,204
Live yeast, CFU/g 200 500 7,100,000 9,700,000
Phase 2 diets
DM, % 90.2 90.1 89.7 89.8
CP, % 18.9 19.0 19.1 19.6
Ca, % 1.38 1.41 1.38 1.33
P, % 0.73 0.72 0.74 0.72
Zn, ppm 234 2,435 257 2,233
Live yeast, CFU/g 300 700 10,500,000 5,900,000
Phase 3 common diet
DM, % 88.4 --- --- ---
CP, % 20.7 --- --- ---
Ca, % 0.95 --- --- ---
P, % 0.61 --- --- ---
Zn, ppm 199 --- --- ---
1Complete diet samples were obtained from each treatment during manufacturing and homogenized to form a 
composite sample. Samples were submitted to Ward Laboratories (Kearney, NE) to analyze DM, CP, Ca, P, and Zn. 
Phase 1 and 2 diets were also sent to Analabs (Fulton, IL) to analyze active live yeast.
2Yeast pre- and probiotics included ActiSaf Sc 47 HR+ at 0.1%, SafMannan at 0.05% and NucleoSaf at 0.05% in 
phase 1 diets, and then concentrations were lowered by 50% in phase 2 diets (Phileo by Lesaffre, Milwaukee, WI).
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Table 3. Interactive effects of yeast probiotics and pharmacological levels of Zn on nursery pig performance1
Item
No yeast probiotics Yeast probiotics
SEM
P =
Low Zn High Zn Low Zn High Zn Yeast × Zn Yeast Zn
BW, lb
d 0 12.4 12.4 12.4 12.4 0.05 0.963 0.779 0.901
d 7 12.8 13.4 13.0 13.4 0.17 0.359 0.508 0.001
d 21 24.0 25.5 24.4 25.5 0.35 0.531 0.533 <0.001
d 42 51.1 52.9 51.3 53.0 0.59 0.912 0.744 0.002
Phase 1 (d 0 to 7)
ADG, lb 0.05 0.14 0.09 0.14 0.021 0.360 0.489 0.001
ADFI, lb 0.15 0.20 0.17 0.19 0.015 0.324 0.847 0.042
F/G 3.09 1.76 2.29 1.04 1.081 0.976 0.474 0.229
Phase 2 (d 7 to 21)
ADG, lb 0.78 0.86 0.81 0.87 0.018 0.546 0.401 <0.001
ADFI, lb 0.96 1.08 1.00 1.09 0.027 0.538 0.507 <0.001
F/G 1.23 1.26 1.23 1.25 0.017 0.777 0.815 0.163
Experimental period (d 0 to 21)
ADG, lb 0.54 0.62 0.57 0.62 0.017 0.400 0.288 <0.001
ADFI, lb 0.69 0.79 0.72 0.79 0.022 0.456 0.461 <0.001
F/G 1.29 1.27 1.27 1.26 0.015 0.806 0.230 0.256
Phase 3 common period (d 21 to 42)
ADG, lb 1.29 1.30 1.28 1.31 0.017 0.685 0.947 0.264
ADFI, lb 1.93 1.92 1.90 1.93 0.024 0.451 0.573 0.811
F/G 1.50 1.47 1.48 1.47 0.012 0.619 0.466 0.146
Overall (d 0 to 42)
ADG, lb 0.91 0.96 0.93 0.97 0.014 0.721 0.433 0.001
ADFI, lb 1.31 1.35 1.31 1.36 0.021 0.982 0.830 0.031
F/G 1.44 1.41 1.42 1.40 0.010 0.518 0.268 0.039
Fecal dry matter, %2
d 4 18.0 19.8 17.5 20.1 1.13 0.708 0.955 0.043
d 21 22.8 21.3 22.5 23.4 1.10 0.281 0.397 0.786
d 42 24.5 24.6 23.5 23.8 1.20 0.909 0.437 0.891
Economics, $
Feed cost/pig3 11.41 11.74 11.76 12.08 0.181 0.997 0.062 0.076
Feed cost/lb gain4 0.306 0.295 0.303 0.298 0.0036 0.345 0.923 0.014
Revenue5 18.76 19.91 19.45 20.29 20.288 0.631 0.100 0.003
IOFC6 7.35 8.17 7.70 8.21 8.210 0.451 0.344 0.002
1A total of 360 barrows (initially 12.4 ± 0.05 lb) were used in a 42-d growth study with 5 pigs per pen and 18 pens per treatment. Yeast pre- and 
probiotics included ActiSaf Sc 47 HR+ at 0.1%, SafMannan at 0.05% and NucleoSaf at 0.05% in phase 1 diets, and then concentrations were 
lowered by 50% in phase 2 diets (Phileo by Lesaffre, Milwaukee, WI). Zinc oxide was added to supply 3,000 ppm of Zn for the duration of phase 1, 
and 2,000 ppm of Zn for the duration of phase 2.
2Fecal samples from the same 3 pigs/pen were collected on d 4, 21, and 42.
3 Feed cost per pig = total feed cost ÷ pigs placed in the pen.
4 Feed cost per lb gain = feed cost per pig ÷ body weight gain per pig.
5 Revenue = (gain per pig × $66.69/cwt) × assumed 75% yield.
6 Income over feed cost = revenue – feed cost per pig.
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SEM P =No yeast Yeast Low Zn High Zn
BW, lb
d 0 12.4 12.4 0.05 0.779 12.4 12.4 0.05 0.901
d 7 13.1 13.2 0.13 0.508 12.9 13.4 0.13 0.001
d 21 24.7 24.9 0.27 0.533 24.2 25.5 0.27 <0.001
d 42 52.0 52.2 0.45 0.744 51.2 52.9 0.45 0.002
Phase 1 (d 0 to 7)
ADG, lb 0.10 0.11 0.016 0.489 0.07 0.14 0.016 0.001
ADFI, lb 0.18 0.18 0.011 0.847 0.16 0.19 0.011 0.042
F/G 2.43 1.66 0.753 0.474 2.69 1.40 0.753 0.229
Phase 2 (d 7 to 21)
ADG, lb 0.82 0.84 0.013 0.401 0.80 0.86 0.013 <0.001
ADFI, lb 1.02 1.04 0.020 0.507 0.98 1.08 0.020 <0.001
F/G 1.25 1.24 0.013 0.815 1.23 1.26 0.013 0.163
Experimental period (d 0 to 21)
ADG, lb 0.58 0.60 0.012 0.288 0.55 0.62 0.012 <0.001
ADFI, lb 0.74 0.75 0.016 0.461 0.71 0.79 0.016 <0.001
F/G 1.28 1.27 0.012 0.230 1.28 1.27 0.012 0.256
Phase 3 common period (d 21 to 42)
ADG, lb 1.30 1.30 0.013 0.947 1.29 1.31 0.013 0.264
ADFI, lb 1.93 1.91 0.018 0.573 1.92 1.92 0.018 0.811
F/G 1.49 1.48 0.009 0.466 1.49 1.47 0.009 0.146
Overall (d 0 to 42)
ADG, lb 0.94 0.95 0.010 0.433 0.92 0.96 0.010 0.001
ADFI, lb 1.33 1.33 0.016 0.830 1.31 1.35 0.016 0.031
F/G 1.42 1.41 0.007 0.268 1.43 1.41 0.007 0.039
Fecal dry matter, %2
d 4 18.9 18.8 0.82 0.955 17.7 20.0 0.82 0.043
d 21 22.0 22.9 0.81 0.397 22.6 22.3 0.81 0.786
d 42 24.5 23.6 0.85 0.437 24.0 24.2 0.85 0.891
Economics, $
Feed cost/pig3 11.58 11.92 0.129 0.062 11.58 11.91 0.129 0.076
Feed cost/lb gain4 0.301 0.300 0.0028 0.923 0.304 0.296 0.0028 0.014
Revenue5 19.34 19.87 0.274 0.100 19.11 20.10 0.274 0.003
IOFC6 7.76 7.95 0.188 0.344 7.52 8.19 0.188 0.002
1A total of 360 barrows (initially 12.4 ± 0.05 lb) were used in a 42-d growth study with 5 pigs per pen and 18 pens per treatment. Yeast pre- and 
probiotics included ActiSaf Sc 47 HR+ at 0.10%, SafMannan at 0.05% and NucleoSaf at 0.05% in phase 1 diets, and then concentrations were 
lowered by 50% in phase 2 diets (Phileo by Lesaffre, Milwaukee, WI). Zinc oxide was added to supply 3,000 ppm of Zn for the duration of phase 
1, and 2,000 ppm of Zn for the duration of phase 2.
2Fecal samples from the same 3 pigs/pen were collected on d 4, 21, and 42.
3 Feed cost per pig = total feed cost ÷ pigs placed in the pen.
4 Feed cost per lb gain = feed cost per pig ÷ body weight gain per pig.
5 Revenue = (gain per pig × $66.69/cwt) × assumed 75% yield.
6 Income over feed cost = revenue – feed cost per pig.
